Please enable JavaScript to view this page correctly
Development_Beta-adrenergic receptors signaling via cAMP
Beta-1 adrenergic receptor , Beta-2 adrenergic receptor and Beta-3 adrenergic receptor
are activated by Epinephrine and L-Noradrenaline . Conventional signaling is accomplished via
G-protein alpha-s / Adenylate cyclase that leads to Cyclic AMP production and activation of PKA-reg (cAMP-dependent) and PKA-cat (cAMP-dependent) [1 ]. AKAP6 is an anchor protein that enables PKA-cat (cAMP-dependent) phosphorylation [2 ], [3 ]. Beta-2 adrenergic receptor signaling
appears to be localized to plasma membrane, unlike that of Beta-1 adrenergic receptor [4 ].
Beta-1 adrenergic receptor coupled
PKA-cat (cAMP-dependent) phosphorylates Phospholamban . Phosphorylation of Phospholamban is believed to release its tonic inhibition of
Ca-ATPase1 and (Ca-ATPase2 and to Ca('2+)
flux to endoplasmatic reticulum. Ca('2+)
flux from cytoplasm accelerates relaxation of cardiac muscle [5 ].
Also PKA-cat (cAMP-dependent) phosphorylates
Troponin I, cardiac . Phosphorylation
prevents Troponin I, cardiac interaction with
Troponin C, cardiac and leads to weaker
Ca('2+) binding and thereby to relaxation of cardiac muscle [5 ], [6 ].
PKA-cat (cAMP-dependent) -mediated phosphorylation of
Troponin I, cardiac is antagonized by
dephosphorylation by PP2A catalytic [7 ].
PKA-cat (cAMP-dependent) phosphorylation of
Ryanodine receptor 2 leads to elevated
Ca('2+) flux to cytoplasm. Elevated
Ca('2+) in cardiac muscles normally has
chronotropic effect [3 ], [5 ].
PKA-cat (cAMP-dependent) , e.g., in cardiomyocytes, activates
PHK alpha (muscle) and
PHK gamma (muscle) / PYGM and this leads to acceleration of glycogen breakdown rate [5 ], [6 ].
Activated by Beta-1 adrenergic receptor and
Beta-2 adrenergic receptor , PKA-cat (cAMP-dependent) participates in activation of L-type Ca(II) channel, alpha 1C subunit . Ca('2+)
current via
(L-type Ca(II) channel, alpha 1C subunit s
elevates Ca('2+) levels
in cytosol. This process leads to contraction of
cardiomyocytes [4 ], [8 ]. Elevated level of Ca('2+) in cardiomyocytes leads to activation of Calmodulin / CaMK II .
CaMK II phospholylates L-type Ca(II) channel, alpha 1C subunit and Phospholamban [5 ]. PKA-cat (cAMP-dependent) -mediated activation of PDE4D and PDE3A leads to
decrease in Cyclic AMP level in cytoplasm due to
conversion of Cyclic AMP to AMP by PDE [5 ], [9 ], [10 ].
PKA-cat (cAMP-dependent)
activated by Beta-2 adrenergic receptor and Beta-3 adrenergic receptor presumably phosphorylates BETA-PIX [11 ] which in turn activates CDC42 / MEKK4(MAP3K4) /
MEK6(MAP2K6) and MEK3(MAP2K3) / p38 MAPK
[12 ], [13 ], leading to relaxation relaxation of cardiac muscle [12 ]. In white/brown adipocytes and intestinal smooth muscle
cells, the above ivents lead to activation of PPARGC1 (PGC1-alpha) / PPAR-gamma .
PPAR-gamma is in a complex with
PPAR-gamma/RXR-alpha that participates
in transcriptional activation of UCP1 .
UCP1 participates in physiological processes
of nonshivering thermogenesis in brown adipocites and in relaxation of intestinal smooth
muscle cells [13 ], [14 ].
PKA-cat (cAMP-dependent)
activated by Beta-3 adrenergic receptor
phosphorylates Lipase hormone-sensitive (LIPS ) and Perilipin , the
latter being a facilitator of LIPS
activity. This way, Beta-3 adrenergic receptor stimulates lipolysis (see lipid catabolic process ) [15 ].
Objects list:
AKAP6
A-kinase anchor protein 6
AMP
Chemical IUPAC name [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Adenylate cyclase
Adenylate cyclase Protein group
BETA-PIX
Rho guanine nucleotide exchange factor 7
Beta-1 adrenergic receptor
Beta-1 adrenergic receptor
Beta-2 adrenergic receptor
Beta-2 adrenergic receptor
Beta-3 adrenergic receptor
Beta-3 adrenergic receptor
CDC42
Cell division control protein 42 homolog
Ca('2+)
Chemical IUPAC name calcium(+2) cation
Ca('2+)
Chemical IUPAC name calcium(+2) cation
Ca-ATPase1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Ca-ATPase2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
CaMK II
CaMK II Complex
Calmodulin
Calmodulin
Cyclic AMP
Chemical IUPAC name (1S,6R,8R,9R)-8-(6-amino-8-bromopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-35-phosphabicyclo[4.3.0]nonan-9-ol
Epinephrine
Chemical IUPAC name 4-[(1R)-1-Hydroxy-2-methylaminoethyl]benzene-1,2-diol
G-protein alpha-s
Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
L-Noradrenaline
Chemical IUPAC name 4-[(1R)-2-Amino-1-hydroxyethyl]benzene-1,2-diol
L-type Ca(II) channel, alpha 1C subunit
Voltage-dependent L-type calcium channel subunit alpha-1C
LIPS
Hormone-sensitive lipase
MEK3(MAP2K3)
Dual specificity mitogen-activated protein kinase kinase 3
MEK6(MAP2K6)
Dual specificity mitogen-activated protein kinase kinase 6
MEKK4(MAP3K4)
Mitogen-activated protein kinase kinase kinase 4
PDE3A
cGMP-inhibited 3',5'-cyclic phosphodiesterase A
PDE4D
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
PHK alpha (muscle)
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform
PHK gamma (muscle)
Phosphorylase b kinase gamma catalytic chain, skeletal muscle isoform
PKA-cat (cAMP-dependent)
Protein kinase, cAMP-dependent, catalytic Protein group
PKA-reg (cAMP-dependent)
Cyclic AMP-dependent protein kinase A regulatory subunit Protein group
PP2A catalytic
Protein phosphatase 2A catalytic Protein group
PPAR-gamma
Peroxisome proliferator-activated receptor gamma
PPAR-gamma/RXR-alpha
PPAR-gamma/RXR-alpha Complex
PPARGC1 (PGC1-alpha)
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
PYGM
Glycogen phosphorylase, muscle form
Perilipin
Perilipin-1
Phospholamban
Cardiac phospholamban
Ryanodine receptor 2
Ryanodine receptor 2
Troponin C, cardiac
Troponin C, slow skeletal and cardiac muscles
Troponin I, cardiac
Troponin I, cardiac muscle
UCP1
Mitochondrial brown fat uncoupling protein 1
p38 MAPK
p38 mitogen-activated protein kinase Protein group
Skeberdis VA
Structure and function of beta3-adrenergic receptors.
Medicina (Kaunas, Lithuania) 2004;40(5):407-13
Fink MA, Zakhary DR, Mackey JA, Desnoyer RW, Apperson-Hansen C, Damron DS, Bond M
AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes.
Circulation research 2001 Feb 16;88(3):291-7
Pare GC, Bauman AL, McHenry M, Michel JJ, Dodge-Kafka KL, Kapiloff MS
The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
Journal of cell science 2005 Dec 1;118(Pt 23):5637-46
Kuschel M, Zhou YY, Cheng H, Zhang SJ, Chen Y, Lakatta EG, Xiao RP
G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling.
The Journal of biological chemistry 1999 Jul 30;274(31):22048-52
Saucerman JJ, McCulloch AD
Cardiac beta-adrenergic signaling: from subcellular microdomains to heart failure.
Annals of the New York Academy of Sciences 2006 Oct;1080:348-61
Kuschel M, Zhou YY, Spurgeon HA, Bartel S, Karczewski P, Zhang SJ, Krause EG, Lakatta EG, Xiao RP
beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart.
Circulation 1999 May 11;99(18):2458-65
Deshmukh PA, Blunt BC, Hofmann PA
Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitor.
American journal of physiology. Heart and circulatory physiology 2007 Feb;292(2):H792-9
Chen-Izu Y, Xiao RP, Izu LT, Cheng H, Kuschel M, Spurgeon H, Lakatta EG
G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels.
Biophysical journal 2000 Nov;79(5):2547-56
Rochais F, Vandecasteele G, Lefebvre F, Lugnier C, Lum H, Mazet JL, Cooper DM, Fischmeister R
Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.
The Journal of biological chemistry 2004 Dec 10;279(50):52095-105
Ding B, Abe J, Wei H, Huang Q, Walsh RA, Molina CA, Zhao A, Sadoshima J, Blaxall BC, Berk BC, Yan C
Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
Circulation 2005 May 17;111(19):2469-76
Lee SH, Eom M, Lee SJ, Kim S, Park HJ, Park D
BetaPix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway. Implication in the regulation of membrane ruffling.
The Journal of biological chemistry 2001 Jul 6;276(27):25066-72
Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP
beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes.
The Journal of biological chemistry 2000 Dec 22;275(51):40635-40
Cao W, Medvedev AV, Daniel KW, Collins S
beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase.
The Journal of biological chemistry 2001 Jul 20;276(29):27077-82
Shabalina I, Wiklund C, Bengtsson T, Jacobsson A, Cannon B, Nedergaard J
Uncoupling protein-1: involvement in a novel pathway for beta-adrenergic, cAMP-mediated intestinal relaxation.
American journal of physiology. Gastrointestinal and liver physiology 2002 Nov;283(5):G1107-16
Robidoux J, Kumar N, Daniel KW, Moukdar F, Cyr M, Medvedev AV, Collins S
Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation.
The Journal of biological chemistry 2006 Dec 8;281(49):37794-802
Developed by WaveAccess